- Home
- Letter to President Obama
- Acknowledgements
- Executive Summary
- Preface
- Part 1: The Case for HPV Vaccination
- Part 2: Urgency for Action
- Part 3: Accelerating HPV Vaccine Uptake in the U.S.
- Part 4: Increasing Global HPV Vaccination
- Part 5: High-Priority Research
- Conclusions
- Appendices
- Appendix A: Workshop Dates and Participants
- Appendix B: Panel Recommendations and Responsible Stakeholders
- Appendix C: Other HPV Vaccine Recommendations and Goals
- Acronyms
Appendix A: Workshop Dates and Participants
| Meeting Date | Location |
|---|---|
| July 24, 2012 | San Francisco, CA |
| September 13, 2012 | Arlington, VA |
| November 16, 2012 | Chicago, IL |
| April 23-24, 2013 | Miami, FL |
| Meeting Participants | |
|---|---|
| Jan Agosti, MD | Bill & Melinda Gates Foundation |
| Kenneth A. Alexander, MD, PhD | The University of Chicago |
| Rachel Ballard-Barbash, MD, MPH | U.S. National Cancer Institute |
| Joan Benson, MD | Merck & Co., Inc. |
| F. Javier Bosch Jose, MD, PhD | Catalan Institute of Oncology (Institut Català d'Oncologia—ICO), Spain |
| Michael T. Brady, MD | Nationwide Children's Hospital |
| Noel T. Brewer, PhD | University of North Carolina Gillings School of Global Public Health Lineberger Comprehensive Cancer Center |
| Karen Canfell, PhD | The University of New South Wales, Australia |
| Philip Castle, PhD, MPH | Global Cancer Initiative |
| Tania Cernuschi, MS | GAVI Alliance, Switzerland |
| Victoria Champion, PhD, RN, FAAN | Indiana University |
| David Chelmow, MD | Virginia Commonwealth University |
| Janine Cory, MPH | U.S. Centers for Disease Control and Prevention |
| Tamera Coyne-Beasley, MD, MPH | University of North Carolina School of Medicine |
| Robert T. Croyle, PhD | U.S. National Cancer Institute |
| Kevin Cullen, MD | University of Maryland Greenebaum Cancer Center |
| Amanda Dempsey, MD, PhD, MPH | University of Colorado School of Medicine |
| Gary Dubin, MD | GlaxoSmithKline Vaccines |
| F. Reed Dulany, III | Dulany Industries, Inc. |
| Donatus U. Ekwueme, PhD | U.S. Centers for Disease Control and Prevention |
| Neal Fowler, MBA | Liquidia Technologies |
| Eduardo L. Franco, DrPH | McGill University, Canada |
| Denise A. Galloway, PhD | Fred Hutchinson Cancer Research Center |
| Maurice Gatera, MPH candidate | Rwanda Biomedical Center, Rwanda |
| Bruce G. Gellin, MD, MPH | U.S. Department of Health and Human Services |
| Maura L. Gillison, MD, PhD | James Cancer Hospital and Comprehensive Cancer Center The Ohio State University |
| Venus Ginés, MPH | Dia de La Mujer Latina Baylor College of Medicine |
| Marc T. Goodman, PhD, MPH | Samuel Oschin Comprehensive Cancer Institute Cedars-Sinai Medical Center |
| Hill Harper, JD | President's Cancer Panel Author, Actor, and Philanthropist |
| Richard M. Haupt, MD, MPH | Merck & Co., Inc. |
| Rolando Herrero, MD, PhD | International Agency for Research on Cancer, France |
| Allan Hildesheim, PhD | U.S. National Cancer Institute |
| Therese Hoyle, BSHE | Hoyle Consulting, Inc. |
| Lenora E. Johnson, DrPH | U.S. National Cancer Institute |
| Nathalia Katz, MD | Ministry of Health, Argentina |
| Judith S. Kaur, MD | Mayo Comprehensive Cancer Center |
| Rima F. Khabbaz, MD | U.S. Centers for Disease Control and Prevention |
| Jane Kim, PhD | Harvard School of Public Health |
| D. Scott LaMontagne, PhD, MPH, FRSPH | University of Washington School of Public Health PATH |
| Eduardo Lazcano, MD, PhD | National Institute of Public Health, Mexico |
| Julie Leask, PhD, MPH | National Centre for Immunisation Research & Surveillance, Australia |
| Douglas R. Lowy, MD | U.S. National Cancer Institute |
| Lauri E. Markowitz, MD | U.S. Centers for Disease Control and Prevention |
| Daniel M. Meyer, DDS | American Dental Association |
| Amy B. Middleman, MD, MSEd, MPH | Texas Children's Hospital Baylor College of Medicine |
| Olufunmilayo I. Olopade, MD, FACP | The University of Chicago Medicine |
| Joel Palefsky, MD | University of California, San Francisco School of Medicine |
| Marcus Plescia, MD, MPH | U.S. Centers for Disease Control and Prevention |
| Cynthia M. Rand, MD, MPH | University of Rochester Medical Center |
| Barbara K. Rimer, DrPH | President's Cancer Panel University of North Carolina Gillings School of Global Public Health |
| Jeff Roberts, MD | U.S. Food and Drug Administration |
| Daniel Rodriguez, MBA | Pan American Health Organization |
| Mitchel C. Rothholz, RPh, MBA | American Pharmacists Association |
| Abby B. Sandler, PhD | President's Cancer Panel U.S. National Cancer Institute |
| Mona Saraiya, MD, MPH | U.S. Centers for Disease Control and Prevention |
| Debbie Saslow, PhD | American Cancer Society |
| Mark Schiffman, MD, MPH | U.S. National Cancer Institute |
| Nathalie Schrameijer, MD | GlaxoSmithKline Biologicals |
| Anne Schuchat, MD | U.S. Centers for Disease Control and Prevention |
| Jennifer S. Smith, PhD, MPH | University of North Carolina Gillings School of Global Public Health |
| Diane Solomon, MD | U.S. National Cancer Institute |
| Shannon Stokley, MPH | U.S. Centers for Disease Control and Prevention |
| John Strand, MEd | FHI 360 |
| Stephen Taplin, MD, MPH | U.S. National Cancer Institute |
| Edward Trimble, MD, MPH | U.S. National Cancer Institute |
| Elizabeth R. Unger, MD, PhD | U.S. Centers for Disease Control and Prevention |
| Claudia Vellozzi, MD, MPH | U.S. Centers for Disease Control and Prevention |
| Susan A. Wang, MD, MPH | World Health Organization, Switzerland |
| Cosette M. Wheeler, PhD | University of New Mexico School of Medicine |
| Owen N. Witte, MD | President's Cancer Panel University of California, Los Angeles |
